Chemotherapy-induced Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Chemotherapy-induced Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-09-19FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
The FDA approved a supplemental application for ondansetron from West-Ward Pharmaceuticals Corp under ANDA 076780, indicating an approved re…
-
FDA approval · 2013-08-30FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
FDA approved a supplemental application for ondansetron hydrochloride from Onesource Specialty Pharma Limited to permit the marketing of thi…
-
FDA approval · 2013-07-19FDA Approved: ONDANSETRON — Original Application (Fresenius Kabi USA, LLC)
FDA approved Fresenius Kabi USA, LLC's original application for a generic ondansetron hydrochloride product.
-
FDA approval · 2013-06-30FDA Approved: ONDANSETRON — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approves a supplemental application for ondansetron from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. This action suppo…
-
FDA approval · 2013-06-30FDA Approved: ONDANSETRON — Supplemental Application (JVET PHARMACEUTICALS LLC)
FDA approved a supplemental application for ondansetron submitted by JVET PHARMACEUTICALS LLC. This action updates the approval for this gen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-06-29FDA Approved: ONDANSETRON — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
The FDA approved a supplemental application for ondansetron submitted by PAI Holdings, LLC dba PAI Pharma.
-
FDA approval · 2013-04-26FDA Approved: ONDANSETRON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Ondansetron from Sun Pharmaceutical Industries, Inc. (ANDA077557).
-
FDA approval · 2013-04-03FDA Approved: ONDANSETRON — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for ondansetron filed by Hikma Pharmaceuticals USA Inc., a supplemental approval for the generic ant…
-
FDA approval · 2013-03-27FDA Approved: EMEND — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for EMEND (aprepitant) from Merck Sharp & Dohme LLC.
-
FDA approval · 2013-03-27FDA Approved: EMEND — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approves a supplemental application for EMEND (fosaprepitant dimeglumine) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2013-03-20FDA Approved: EMEND — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for EMEND (aprepitant) filed by Merck Sharp & Dohme LLC. The action relates to the approved anti…
-
FDA approval · 2013-03-19FDA Approved: ONDANSETRON — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for ondansetron from Hikma Pharmaceuticals USA Inc., confirming approval of a generic ondansetron pr…
-
FDA approval · 2013-02-22FDA Approved: ONDANSETRON HYDROCHLORIDE — Original Application (Baxter Healthcare Corporation)
The FDA approved Baxter Healthcare Corporation's original ANDA for ondansetron hydrochloride, enabling a generic version of ondansetron to b…
-
FDA approval · 2013-02-14FDA Approved: GRANISETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for Granisetron (granisetron hydrochloride) from Fresenius Kabi USA, LLC.
-
FDA approval · 2013-02-14FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)
The FDA approved Cumberland Pharmaceuticals' supplemental application for SANCUSO (granisetron).
-
FDA approval · 2012-12-21FDA Approved: ONDANSETRON — Original Application (Eugia US LLC)
FDA approved the original application for ondansetron hydrochloride by Eugia US LLC. The generic drug is indicated to prevent nausea and vom…
-
FDA approval · 2012-12-21FDA Approved: ONDANSETRON — Original Application (Eugia US LLC)
FDA approves Eugia US LLC's original application for ondansetron hydrochloride, granting generic approval for this antiemetic under the ANDA…
-
FDA approval · 2012-09-24FDA Approved: APREPITANT — Original Application (Sandoz Inc)
The FDA approved Sandoz Inc's original ANDA for aprepitant, a generic NK1 receptor antagonist, for the prevention of chemotherapy-induced na…
-
FDA approval · 2012-09-10FDA Approved: METOCLOPRAMIDE — Supplemental Application (Genus Lifesciences Inc.)
The FDA approved a supplemental application for metoclopramide hydrochloride from Genus Lifesciences Inc., completing regulatory action for …
-
FDA approval · 2012-06-15FDA Approved: ONDANSETRON — Original Application (JVET PHARMACEUTICALS LLC)
FDA approved a generic ondansetron product from JVET Pharmaceuticals LLC under the Original Application, authorizing its marketing.
-
FDA approval · 2012-04-30FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
FDA approved a supplemental application for ondansetron from West-Ward Pharmaceuticals Corp under ANDA076781. This action grants regulatory …
-
FDA approval · 2012-04-30FDA Approved: ONDANSETRON — Supplemental Application (West-Ward Pharmaceuticals Corp)
The FDA approved a supplemental application for ondansetron submitted by West-Ward Pharmaceuticals Corp under ANDA076780, authorizing change…
-
FDA approval · 2012-04-27FDA Approved: ONDANSETRON — Supplemental Application (AvPAK)
FDA approves a supplemental application for ondansetron from AvPAK under an ANDA. This action updates the labeling/approval status of this g…
-
FDA approval · 2012-04-18FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
The FDA approved a supplemental application for granisetron hydrochloride from Mylan Institutional LLC, enabling its continued marketing as …
-
FDA approval · 2012-04-18FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for granisetron hydrochloride (generic) from Mylan Institutional LLC. This action updates the produc…